Correlation Between NewAmsterdam Pharma and CEL SCI
Can any of the company-specific risk be diversified away by investing in both NewAmsterdam Pharma and CEL SCI at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NewAmsterdam Pharma and CEL SCI into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NewAmsterdam Pharma and CEL SCI Corp, you can compare the effects of market volatilities on NewAmsterdam Pharma and CEL SCI and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NewAmsterdam Pharma with a short position of CEL SCI. Check out your portfolio center. Please also check ongoing floating volatility patterns of NewAmsterdam Pharma and CEL SCI.
Diversification Opportunities for NewAmsterdam Pharma and CEL SCI
0.26 | Correlation Coefficient |
Modest diversification
The 3 months correlation between NewAmsterdam and CEL is 0.26. Overlapping area represents the amount of risk that can be diversified away by holding NewAmsterdam Pharma and CEL SCI Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CEL SCI Corp and NewAmsterdam Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NewAmsterdam Pharma are associated (or correlated) with CEL SCI. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CEL SCI Corp has no effect on the direction of NewAmsterdam Pharma i.e., NewAmsterdam Pharma and CEL SCI go up and down completely randomly.
Pair Corralation between NewAmsterdam Pharma and CEL SCI
Given the investment horizon of 90 days NewAmsterdam Pharma is expected to under-perform the CEL SCI. But the stock apears to be less risky and, when comparing its historical volatility, NewAmsterdam Pharma is 2.46 times less risky than CEL SCI. The stock trades about -0.37 of its potential returns per unit of risk. The CEL SCI Corp is currently generating about -0.11 of returns per unit of risk over similar time horizon. If you would invest 45.00 in CEL SCI Corp on November 28, 2024 and sell it today you would lose (9.00) from holding CEL SCI Corp or give up 20.0% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
NewAmsterdam Pharma vs. CEL SCI Corp
Performance |
| Timeline |
| NewAmsterdam Pharma |
| CEL SCI Corp |
NewAmsterdam Pharma and CEL SCI Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with NewAmsterdam Pharma and CEL SCI
The main advantage of trading using opposite NewAmsterdam Pharma and CEL SCI positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NewAmsterdam Pharma position performs unexpectedly, CEL SCI can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CEL SCI will offset losses from the drop in CEL SCI's long position.| NewAmsterdam Pharma vs. Monte Rosa Therapeutics | NewAmsterdam Pharma vs. Inventiva Sa | NewAmsterdam Pharma vs. Cullinan Oncology LLC | NewAmsterdam Pharma vs. Compass Therapeutics |
| CEL SCI vs. Beam Therapeutics | CEL SCI vs. Editas Medicine | CEL SCI vs. Caribou Biosciences | CEL SCI vs. Verve Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Other Complementary Tools
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |